Fingerprint
Dive into the research topics of 'A phase I trial of docetaxel/estramustine/imatinib in patients with hormone-refractory prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I trial of docetaxel/estramustine/imatinib in patients with hormone-refractory prostate cancer
Amy M. Lin, Brian I. Rini, Mika K. Derynck, Vivian Weinberg, Margaret Park, Charles J. Ryan, Jonathan E. Rosenberg, Glenn Bubley, Eric J. Small
Research output: Contribution to journal › Article › peer-review
32
Scopus
citations